Abstract:As the most versatile and precise gene editing technology, prime editing (PE) can establish a durable cure for most human genetic disorders. Several generations of PE have been developed based on an editor machine or prime editing guide RNA (pegRNA) to achieve any kind of genetic correction. However, due to the early stage of development, PE complex elements need to be optimized for more efficient editing. Smart optimization of editor proteins as well as pegRNA has been contemplated by many researchers, but the universal PE machine's current shortcomings remain to be solved. The modification of PE elements, fine-tuning of the host genes, manipulation of epigenetics, and blockage of immune responses could be used to reach more efficient PE. Moreover, the host factors involved in the PE process, such as repair and innate immune system genes, have not been determined, and PE cell context dependency is still poorly understood. Regarding the large size of the PE elements, delivery is a significant challenge and the development of a universal viral or nonviral platform is still far from complete. PE versions with shortened variants of reverse transcriptase are still too large to fit in common viral vectors. Overall, PE faces challenges in optimization for efficiency, high context dependency during the cell cycling, and delivery due to the large size of elements. In addition, immune responses, unpredictability of outcomes, and off-target effects further limit its application, making it essential to address these issues for broader use in nonpersonalized gene editing. Besides, due to the limited number of suitable animal models and computational modeling, the prediction of the PE process remains challenging. In this review, the fundamentals of PE, including generations, potential, optimization, delivery, in vivo barriers, and the future landscape of the technology are discussed.

Integrating Prime Editing and Cellular Reprogramming as Novel Strategies for Genetic Cardiac Disease Modeling and Treatment

Genomic Engineering of Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Prime editing: Its systematic optimization and current applications in disease treatment and agricultural breeding

hPSC gene editing for cardiac disease therapy

Recent advances in prime editing technologies and their promises for therapeutic applications

Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy

Recent Therapeutic Gene Editing Applications to Genetic Disorders

Highly efficient generation of isogenic pluripotent stem cell models using prime editing

Development and application of CRISPR/Cas9 technologies in genomic editing.

A robust and inducible precise genome editing via an all-in-one prime editor in human pluripotent stem cells

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Prime Editing for Human Gene Therapy: Where Are We Now?

Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and Challenges

Emerging Perspectives on Prime Editor Delivery to the Brain

Prime editing for precise and highly versatile genome manipulation

CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment

Gene editing in common cardiovascular diseases

Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9

Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair